Pharma BD Deal Intelligence

Endo Pharmaceuticals Inc. / SkyePharma plc

2003 · Co-Development · $120M · Complete

Endo paid $120M for rights to Depomorphine and Propofol IDD-D plus options on additional SkyePharma assets. Sources: Endo Pharmaceuticals 10-K (year 2003), industry coverage.

Key facts

• Announced Dec 19, 2003
• Deal value $120M
• Deal type Co-Development

← Browse all deals  ·  How we score deals